Related topics

EyePoint Pharmaceuticals: Fiscal 4Q Earnings Snapshot

September 12, 2018

WATERTOWN, Mass. (AP) _ EyePoint Pharmaceuticals (EYPT) on Wednesday reported a loss of $34.4 million in its fiscal fourth quarter.

The Watertown, Massachusetts-based company said it had a loss of 62 cents per share. Losses, adjusted for non-recurring costs, were 19 cents per share.

The drug delivery technology company posted revenue of $715,000 in the period.

For the year, the company reported that its loss widened to $53.2 million, or $1.15 per share. Revenue was reported as $3 million.

The company’s shares closed at $2.29. A year ago, they were trading at $1.37.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on EYPT at https://www.zacks.com/ap/EYPT

Update hourly